SCHEDULE: Beryl Capital Exits Entire Nevro Corp Stake
Beneficial Ownership Amendment
Beryl Capital Management and its affiliates have reported divesting their entire beneficial ownership in Nevro Corp, now holding 0% of the common stock.
Summary
- Beryl Capital Management LLC, Beryl Capital Management LP, Beryl Capital Partners II LP, and David A. Witkin have filed an Amendment No. 1 to Schedule 13G.
- The reporting persons collectively hold 0% of Nevro Corp's Common Stock, indicating a complete divestment of their previous beneficial ownership.
- The event triggering this filing occurred on June 30, 2025, which is the date they ceased to be a reportable beneficial owner.
Sentiment
Score: 3
Explanation: The complete divestment by an institutional investor is a negative signal, indicating a lack of confidence or a strategic exit from the company's stock.
Negatives
- The complete divestment by Beryl Capital Management and its affiliates signals a loss of institutional support for Nevro Corp.
- This exit may indicate a lack of confidence in Nevro Corp's future prospects or a strategic shift away from the company by a significant institutional investor.
Future Outlook
NA
Industry Context
This filing reflects a specific institutional investor's portfolio decision regarding Nevro Corp and does not provide broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: May view the divestment as a negative signal, potentially leading to downward pressure on the stock price.
- Employees: Indirectly impacted by potential stock price volatility or changes in investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event requiring the filing (cessation of reportable beneficial ownership). |
| 07/31/2025 | Signature date for all reporting persons on the Schedule 13G. |
| 08/05/2025 | Date of the Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G. |
Recommendation
sellThe complete exit of a significant institutional investor like Beryl Capital Management suggests a lack of conviction in Nevro Corp's future prospects. This action by a sophisticated investor often precedes or accompanies periods of underperformance, making a 'sell' recommendation prudent for existing holders and advising against new positions.
Keywords
Nevro Corp, NVRO, Beryl Capital Management, Schedule 13G, Beneficial Ownership, Institutional Investor, Divestment, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.